Anaptysbio, Inc.

This study tests a new drug called rosnilimab in 132 adults with moderate to severe ulcerative colitis, a condition causing inflammation in the colon. Participants receive either the drug or a placebo to see if it reduces disease activity and improves symptoms like diarrhea and b…